Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids

The synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectro...

Full description

Saved in:
Bibliographic Details
Main Authors: Irum Shahzadi, Ameer Fawad Zahoor, Bushra Parveen, Azhar Rasul, Zohaib Raza, Sajjad Ahmad, Ali Irfan, Gamal A. El-Hiti
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Chemistry
Online Access:http://dx.doi.org/10.1155/2022/3502872
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565811633455104
author Irum Shahzadi
Ameer Fawad Zahoor
Bushra Parveen
Azhar Rasul
Zohaib Raza
Sajjad Ahmad
Ali Irfan
Gamal A. El-Hiti
author_facet Irum Shahzadi
Ameer Fawad Zahoor
Bushra Parveen
Azhar Rasul
Zohaib Raza
Sajjad Ahmad
Ali Irfan
Gamal A. El-Hiti
author_sort Irum Shahzadi
collection DOAJ
description The synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectroscopic methods. The synthesized acefyllines demonstrated moderate activity (cell viability = 22.55 ± 0.95% − 57.63 ± 3.65%) compared with the starting drug acefylline (cell viability = 80 ± 3.87%) against the human liver carcinoma (Hep G2 cell line). N-(4-Chlorophenyl)-2-(4-(3,4-dichlorophenyl)-5-((1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetamide exhibited the most potent activity (cell viability = 22.55 ± 0.95%) among the synthesized derivatives. The in silico modeling studies were performed to predict the binding of the most potent derivative with a binding site that agreed with the results of the antiproliferative activity. The newly synthesized heterocycles exhibited the least hemolytic and moderate clot lysis activity.
format Article
id doaj-art-b6864fcf9ed641859ab4a94e2fa80003
institution Kabale University
issn 2090-9071
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Chemistry
spelling doaj-art-b6864fcf9ed641859ab4a94e2fa800032025-02-03T01:06:38ZengWileyJournal of Chemistry2090-90712022-01-01202210.1155/2022/3502872Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole HybridsIrum Shahzadi0Ameer Fawad Zahoor1Bushra Parveen2Azhar Rasul3Zohaib Raza4Sajjad Ahmad5Ali Irfan6Gamal A. El-Hiti7Department of ChemistryDepartment of ChemistryDepartment of ChemistryDepartment of ZoologyDepartment of PharmacologyDepartment of ChemistryDepartment of ChemistryCornea Research ChairThe synthesis of novel acefyllines and exploring their biological activities attract researchers due to their medicinal applications. Therefore, the current work reports the successful synthesis of a series of novel acefyllines in good yields, and their structures wereconfirmed using various spectroscopic methods. The synthesized acefyllines demonstrated moderate activity (cell viability = 22.55 ± 0.95% − 57.63 ± 3.65%) compared with the starting drug acefylline (cell viability = 80 ± 3.87%) against the human liver carcinoma (Hep G2 cell line). N-(4-Chlorophenyl)-2-(4-(3,4-dichlorophenyl)-5-((1,3-dimethyl-2,6-dioxo-2,3-dihydro-1H-purin-7(6H)-yl)methyl)-4H-1,2,4-triazol-3-ylthio)acetamide exhibited the most potent activity (cell viability = 22.55 ± 0.95%) among the synthesized derivatives. The in silico modeling studies were performed to predict the binding of the most potent derivative with a binding site that agreed with the results of the antiproliferative activity. The newly synthesized heterocycles exhibited the least hemolytic and moderate clot lysis activity.http://dx.doi.org/10.1155/2022/3502872
spellingShingle Irum Shahzadi
Ameer Fawad Zahoor
Bushra Parveen
Azhar Rasul
Zohaib Raza
Sajjad Ahmad
Ali Irfan
Gamal A. El-Hiti
Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
Journal of Chemistry
title Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
title_full Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
title_fullStr Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
title_full_unstemmed Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
title_short Acefylline Derivatives as a New Class of Anticancer Agents: Synthesis, Molecular Docking, and Anticancer, Hemolytic, and Thrombolytic Activities of Acefylline-Triazole Hybrids
title_sort acefylline derivatives as a new class of anticancer agents synthesis molecular docking and anticancer hemolytic and thrombolytic activities of acefylline triazole hybrids
url http://dx.doi.org/10.1155/2022/3502872
work_keys_str_mv AT irumshahzadi acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT ameerfawadzahoor acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT bushraparveen acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT azharrasul acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT zohaibraza acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT sajjadahmad acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT aliirfan acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids
AT gamalaelhiti acefyllinederivativesasanewclassofanticanceragentssynthesismoleculardockingandanticancerhemolyticandthrombolyticactivitiesofacefyllinetriazolehybrids